Journal of Clinical and Experimental Ophthalmology
Open Access

Abstract

Age related macular degeneration is a multifactorial disease involving genetic and environmental factors. Newer drugs targeting complement pathway (Eculizumab, Lampalizumab), gene therapy and stem cell therapy are recent innovations for the treatment of age related macular degeneration.

Author Info

Published: 09-Sep-2021

Copyright: This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.